Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 1809: LncRNA-SOX2-OT contributes to head and neck cancer cell proliferation by regulating DDIT4

View through CrossRef
Abstract Background: Long non-coding RNAs (lncRNAs) have been shown to serve as an oncogenic role in human cancers. However, the role of lncRNAs in head and neck squamous cell carcinoma (HNSCC) is still unclear. Methods and Results: Our previous microarray analysis showed that lncRNA SOX2-OT was upregulated in HNSCC tumor tissues and was correlated with DDIT4. To determine whether SOX2-OT served as a poor prognosis factor and targeted DDIT4 to facilitate cell proliferation and tumorigenesis in human HNSCC, qRT-PCR tested the relative expression of SOX2-OT and DDIT4 in 60 pairs of LSCC cancer tissues and the corresponding adjacent non-cancer tissues. Cell functional assay was conducted in vitro. We validated the up-regulation of SOX2-OT and DDIT4 in HNSCC tissues. Furthermore, we found that high SOX2-OT expression was significantly associated with advanced tumor differentiation, and worse prognosis. In vitro experiments demonstrated that SOX2-OT functioned as an oncogene by promoting cell proliferation and inhibiting cell apoptosis, and SOX2-OT targeted DDIT4 as its competing endogenous RNA in HNSCC cells. Conclusions: Our findings for the first time identify the oncogenic role of SOX2-OT in HNSCC, demonstrating that SOX2-OT is a potential prognostic biomarker and promising therapeutic target in HNSCC. Note: This abstract was not presented at the meeting. Citation Format: Ru Wang, Yifan Yang, Chen Tan, Ling Feng, Jugao Fang. LncRNA-SOX2-OT contributes to head and neck cancer cell proliferation by regulating DDIT4 [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1809.
Title: Abstract 1809: LncRNA-SOX2-OT contributes to head and neck cancer cell proliferation by regulating DDIT4
Description:
Abstract Background: Long non-coding RNAs (lncRNAs) have been shown to serve as an oncogenic role in human cancers.
However, the role of lncRNAs in head and neck squamous cell carcinoma (HNSCC) is still unclear.
Methods and Results: Our previous microarray analysis showed that lncRNA SOX2-OT was upregulated in HNSCC tumor tissues and was correlated with DDIT4.
To determine whether SOX2-OT served as a poor prognosis factor and targeted DDIT4 to facilitate cell proliferation and tumorigenesis in human HNSCC, qRT-PCR tested the relative expression of SOX2-OT and DDIT4 in 60 pairs of LSCC cancer tissues and the corresponding adjacent non-cancer tissues.
Cell functional assay was conducted in vitro.
We validated the up-regulation of SOX2-OT and DDIT4 in HNSCC tissues.
Furthermore, we found that high SOX2-OT expression was significantly associated with advanced tumor differentiation, and worse prognosis.
In vitro experiments demonstrated that SOX2-OT functioned as an oncogene by promoting cell proliferation and inhibiting cell apoptosis, and SOX2-OT targeted DDIT4 as its competing endogenous RNA in HNSCC cells.
Conclusions: Our findings for the first time identify the oncogenic role of SOX2-OT in HNSCC, demonstrating that SOX2-OT is a potential prognostic biomarker and promising therapeutic target in HNSCC.
Note: This abstract was not presented at the meeting.
Citation Format: Ru Wang, Yifan Yang, Chen Tan, Ling Feng, Jugao Fang.
LncRNA-SOX2-OT contributes to head and neck cancer cell proliferation by regulating DDIT4 [abstract].
In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA.
Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1809.

Related Results

Glioma SOX2 expression decreased after adjuvant therapy
Glioma SOX2 expression decreased after adjuvant therapy
Abstract Objectives: SOX2 is regarded as an important marker in stem cell. The change of SOX2 expression after adjuvant therapy in high grade glioma (HGG) remains unknown s...
Glioma SOX2 expression decreased after adjuvant therapy
Glioma SOX2 expression decreased after adjuvant therapy
Abstract Objectives SOX2 is regarded as an important marker in stem cell. The change of SOX2 expression after adjuvant therapy in high grade glioma (HGG) remains unknown s...
Glioma SOX2 expression decreased after adjuvant therapy
Glioma SOX2 expression decreased after adjuvant therapy
Abstract SOX2 is regarded as an important marker in stem cell. The change of SOX2 expression after adjuvant therapy in high grade glioma (HGG) remains unknown so far. Few p...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Abstract IA3: Regulatory networks in onco-lncRNAomics: Cis-regulation and non-conservation
Abstract IA3: Regulatory networks in onco-lncRNAomics: Cis-regulation and non-conservation
Abstract Global studies of the transcriptome reveal that approximately half of human transcriptional units (genes) encode solely non-protein-coding RNAs (ncRNAs), wh...
Data from Sox2 Requirement in Sonic Hedgehog-Associated Medulloblastoma
Data from Sox2 Requirement in Sonic Hedgehog-Associated Medulloblastoma
<div>Abstract<p>The transcription factor Sox2 has been shown to play essential roles during embryonic development as well as in cancer. To more precisely understand tum...
Data from Sox2 Requirement in Sonic Hedgehog-Associated Medulloblastoma
Data from Sox2 Requirement in Sonic Hedgehog-Associated Medulloblastoma
<div>Abstract<p>The transcription factor Sox2 has been shown to play essential roles during embryonic development as well as in cancer. To more precisely understand tum...

Back to Top